Soluble urokinase plasminogen activator receptor (SuPAR) in patients with plasma cell dyscrasias, a pilot study

被引：0
|
作者：
Sudhini, Yashwanth [1 ]
Dhakal, Binod [2 ]
Reiser, Jochen [1 ]
Altintas, Mehmet [1 ]
Hahm, Eunsil [1 ]
Peev, Vasil [1 ]
Venugopal, Parameswaran [1 ]
Paner, Agne [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-441
引用
收藏
页码：S283 / S284
页数：2
相关论文
共 50 条
  • [31] Prognostic value of soluble urokinase plasminogen activator receptor (suPAR) in patients admitted with acute heart failure
    Kandiah, A.
    Taraldsen, I
    El-Sheikh, M.
    El Caidi, N. Olsen
    Wisborg, F. Dencker
    Hove, J. Dahlgaard
    Grand, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [32] Soluble urokinase plasminogen activator receptor (suPAR) predicts 1 year mortality in patients with acute breathlessness
    Chew-Harris, J. S.
    Appleby, S.
    Richards, A. M.
    Troughton, R. W.
    Pemberton, C. J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1573 - 1573
  • [33] Soluble urokinase plasminogen activator receptor (suPAR) as a novel biomarker in patients undergoing resection of pancreatic adenocarcinoma
    Loosen, Sven H.
    Binneboesel, Marcel
    Longerich, Thomas
    Roderburg, Christoph
    Trautwein, Christian
    Neumann, Ulf Peter
    Luedde, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [34] Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
    Manfredi, Mariangela
    Van Hoovels, Lieve
    Benucci, Maurizio
    De Luca, Riccardo
    Coccia, Carmela
    Bernardini, Pamela
    Russo, Edda
    Amedei, Amedeo
    Guiducci, Serena
    Grossi, Valentina
    Bossuyt, Xavier
    Perricone, Carlo
    Infantino, Maria
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [35] A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells
    Mizukami, IF
    Todd, RF
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (02) : 203 - 213
  • [36] Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease
    Fueller, D.
    Liu, C.
    Ko, Y. -A.
    Alkhoder, A.
    Desai, S. R.
    Almuwaqqat, Z.
    Patel, S. A.
    Ejaz, K.
    Kauser, T.
    Martini, A.
    Alvi, Z.
    Mehta, P. K.
    Sperling, L. S.
    Quyyumi, A. A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [37] Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Emergency Department (Ed): A Tool for the Assessment of Elderly Patients
    Holstein, Ria M.
    Seppala, Santeri
    Kaartinen, Johanna
    Hongisto, Mari
    Hyppola, Harri
    Castren, Maaret
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [38] Usefulness of soluble urokinase plasminogen activator receptor (suPAR) as an inflammatory biomarker in obese children
    Kosecik, Mustafa
    Dervisoglu, Pinar
    Koroglu, Mehmet
    Isguven, Pinar
    Elmas, Bahri
    Demiray, Tayfur
    Altindis, Mustafa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 228 : 158 - 161
  • [39] Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
    Phuong Anh Le Thy
    Thuy Yen Hoang Thi
    Kiem Hao Tran
    Huu Son Nguyen
    Egyptian Pediatric Association Gazette, 70
  • [40] Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
    Hoybye, Charlotte
    Faseh, Laia
    Himonakos, Christos
    Pielak, Tomasz
    Eugen-Olsen, Jesper
    ENDOCRINE CONNECTIONS, 2019, 8 (06): : 772 - 779
12345